Acute promyelocytic leukemia Primary Prevention: Difference between revisions
Line 15: | Line 15: | ||
There are no available vaccines against acute promyelocytic leukemia . | There are no available vaccines against acute promyelocytic leukemia . | ||
Effective measures for the primary prevention of acute promyelocytic leukemia include: | Effective measures for the primary prevention of acute promyelocytic leukemia include:<ref name="pmid250566972">{{cite journal |vauthors=Grove CS, Vassiliou GS |title=Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? |journal=Dis Model Mech |volume=7 |issue=8 |pages=941–51 |date=August 2014 |pmid=25056697 |doi=10.1242/dmm.015974 |url=}}</ref> | ||
*White blood cell (WBC) count more than 10,000,000,000 | *White blood cell (WBC) count more than 10,000,000,000 | ||
*Advanced age (Age> 60) | *Advanced age (Age> 60)<ref name="pmid22166497">{{cite journal |vauthors=McHale CM, Zhang L, Smith MT |title=Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment |journal=Carcinogenesis |volume=33 |issue=2 |pages=240–52 |date=February 2012 |pmid=22166497 |pmc=3271273 |doi=10.1093/carcin/bgr297 |url=}}</ref> | ||
*Prevent to exposure benzene | |||
* | * | ||
OR | OR |
Revision as of 20:19, 25 January 2019
Acute promyelocytic leukemia Microchapters |
Differentiating Acute promyelocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute promyelocytic leukemia Primary Prevention On the Web |
American Roentgen Ray Society Images of Acute promyelocytic leukemia Primary Prevention |
Directions to Hospitals Treating Acute promyelocytic leukemia |
Risk calculators and risk factors for Acute promyelocytic leukemia Primary Prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no established measures for the primary prevention of acute promyelocytic leukemia
There are no available vaccines against acute promyelocytic leukemia .
Effective measures for the primary prevention of acute promyelocytic leukemia in fatal is
Primary Prevention
There are no established measures for the primary prevention of acute promyelocytic leukemia .
There are no available vaccines against acute promyelocytic leukemia .
Effective measures for the primary prevention of acute promyelocytic leukemia include:[1]
- White blood cell (WBC) count more than 10,000,000,000
- Advanced age (Age> 60)[2]
- Prevent to exposure benzene
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
References
- ↑ Grove CS, Vassiliou GS (August 2014). "Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?". Dis Model Mech. 7 (8): 941–51. doi:10.1242/dmm.015974. PMID 25056697.
- ↑ McHale CM, Zhang L, Smith MT (February 2012). "Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment". Carcinogenesis. 33 (2): 240–52. doi:10.1093/carcin/bgr297. PMC 3271273. PMID 22166497.